Newer mAb Bests Standard Therapy for Less Risky Renal Tx - MedPage Today PDF Print
MedPage Today
Explain that alemtuzumab was effective at preventing early rejection episodes in renal transplant recipients undergoing an early glucocorticoid wean compared with basiliximab or antithymocyte globulin.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.